Profilo
Leena Gandhi is currently the Director at Bright Peak Therapeutics, Inc. and the Chief Medical Officer at Nextpoint Therapeutics, Inc. She previously worked as an Independent Non-Executive Director at NexImmune, Inc. from 2022 to 2024, as the Director-Cancer Therapeutic Innovation at Dana-Farber Cancer Institute, Inc. from 2020 to 2023, as the Director-Thoracic Medical Oncology at New York University from 2016 to 2018, and as the Vice President-Immuno Oncology Development at Eli Lilly & Co. from 2018 to 2020.
Dr. Gandhi received her undergraduate degree from the University of Utah, her graduate degree from New York University in 2002, and her doctorate degree from the University of California, Berkeley in 1998.
Posizioni attive di Leena Gandhi
| Società | Posizione | Inizio |
|---|---|---|
Bright Peak Therapeutics, Inc.
Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for the treatment of cancer and autoimmune diseases | Direttore/Membro del Consiglio | 28/02/2022 |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates life sciences research and development company | Direttore Tecnico/Scientifico/R&S | 01/01/2023 |
Precedenti posizioni note di Leena Gandhi
| Società | Posizione | Fine |
|---|---|---|
| NEXIMMUNE, INC. | Direttore/Membro del Consiglio | 27/08/2024 |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Corporate Officer/Principal | 01/01/2023 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/05/2020 |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/06/2018 |
Formazione di Leena Gandhi
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
NexImmune, Inc.
NexImmune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops T cell immunotherapies | Health Technology |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
University of Utah
University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates life sciences research and development company | Commercial Services |
Bright Peak Therapeutics, Inc.
Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
















